Compare BioNTech SE - ADR (BNTX) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Vipshop Holdings Ltd - ADR — how do they compare? BioNTech SE - ADR trades at $89.89 (market cap $22.86B), while Vipshop Holdings Ltd - ADR trades at $13.91 (market cap $6.66B). The key difference: BioNTech SE - ADR is far larger — about 3.4× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays a 4.47% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | VIPS | |
|---|---|---|
Market Cap | $22.86B | $6.66B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $20.68 |
52-Week Low | $83.89 | $12.92 |
Enterprise Value | $6.53B | $3.25B |
Dividend Yield | — | 4.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BioNTech (BNTX) trades at $90.07, down 1.55% today, amid a bearish technical signal and declining revenue trends. The company reported a net loss of $1.14 billion in 2025, with profitability metrics negative, though it maintains a strong cash position of $16.78 billion. Recent news highlights restructuring efforts, including site closures and a $1 billion share buyback, as it pivots focus to oncology pipeline development following reduced COVID-19 vaccine demand.
The outlook remains challenging with persistent losses and competitive pressures, but analyst consensus is bullish with a $129.67 price target. Key risks include execution of the oncology strategy and revenue volatility. The stock's current valuation reflects uncertainty, offering potential upside if pipeline milestones are met, but investors face significant operational and market headwinds.
Vipshop Holdings (VIPS) trades at $13.92, down slightly by 0.14% on the day, with a bullish technical signal supported by strong ADX readings. The stock presents attractive valuation metrics with a P/E of 6.35 and P/S of 0.45, while maintaining solid profitability with an 18.43% ROE. Recent Q1 2026 earnings matched expectations, and the company is pursuing growth through outlet store spin-offs into a REIT structure.
The outlook remains positive given deep value multiples and analyst consensus leaning buy, though risks include revenue pressure from a later Chinese New Year and competitive e-commerce headwinds. Upside potential hinges on execution of the outlet strategy and return to sustained revenue growth in FY2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
